Dogecoin Cash, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Dogecoin Cash, Inc. posted a substantially wider net loss for fiscal year 2025, primarily due to a significant impairment charge on its digital asset holdings, despite a reduction in its operating loss from core telemedicine services.
Dogecoin Cash, Inc., formerly Cannabis Sativa, Inc., reports a decrease in revenue for fiscal year 2024 and outlines its strategic focus on telemedicine expansion and cryptocurrency integration for 2025.
Dogecoin Cash, Inc. files an amended 10-K to correct a title omission and reports a 25% decrease in revenue for the fiscal year ended December 31, 2023, primarily due to increased competition in the cannabis telemedicine industry.
10-K: Cannabis Sativa Inc. Reports 2023 Annual Results, Revenue Declines Amid Telemedicine Competition
Cannabis Sativa Inc. reports a 25% decrease in revenue for 2023, primarily due to increased competition in the telemedicine sector, while also highlighting strategic shifts towards brand development and product marketing.